ormeloxifene
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background: DUB is defined as abnormal uterine bleeding without any clinically detectable pelvic pathology. The present study was…
Objective: To study the efficacy and safety of ormeloxifene in the medical management of AUB. Methods: 50 women with HMB who…
Background: During womens reproductive years, heavy menstrual bleeding (HMB) (abnormal uterine bleeding; AUB) is the most common…
Method: The study was a prospective clinical observation undertaken to evaluate the efficacy of ormeloxifene in uterine fibroid…
Breast pain or mastalgia is one of the most common benign disorders of breast. Several agents have been tried in the treatment of…
To evaluate the efficacy of Ormeloxifene in DUB. Medical management of DUB is a challenging task and many drugs are available for…
Objective: To assess the efficacy and safety of ormeloxifene (centchroman) in the medical management of menorrhagia. Materials…
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL
Background: Cervical cancer is one of the most…
ORMELOXIFNE - A new Treatment Modality in DUB Dr. Surendra Nath Panda, M.S. Professor of Obstetrics and Gynaecology M.K.C.G…